Center for Vital Longevity
In 2015, the Aging Mind Foundation awarded a $208,950 grant to Center for Vital Longevity. This grant was used to support research to further advancements in the field of cognitive neuroscience of aging through a three-year postdoctoral fellowship awarded to Dr. Sara Festini. Dr. Festini’s research focuses on cognition and brain function in busy people versus people who are less active and more relaxed.
Center for Brain Health
In 2016, the Aging Mind Foundation awarded a $220,000 grant to Center for Brain Health. This grant was used to focus on the exploration of cognitive behavior and other biomarkers found in early mild cognitive impairment participants by using experimental modalities through a three-year postdoctoral fellowship awarded to Dr. Namrata Singh. Her research interests include understanding the process and stages of dementia using advanced brain scans and other technologically advanced techniques.
Baylor AT&T Memory Center
In 2017, the Aging Mind Foundation awarded a $400,000 grant to Baylor AT&T Memory Center. A portion of this grant has been used to fund the TGen research project where Baylor AT&T Memory Center patient-physician researchers are partnering with TGen, a genomics research center, to conduct a gene sequencing study on “outlier” Alzheimer’s patients, which has not been done before. TGen’s previous research suggests that these patients may have rare genetic mutations in known Alzheimer’s disease genes. This study will be valuable because, until now, power analyses of this nature have only focused on patients who are high-risk and/or have a family history of Alzheimer’s disease and whose disease can be predicted because of a known genetic mutation.
The remainder of the grant is currently held in a research fund and will be used to fund a future research project with Baylor AT&T Memory Center.
UNIVERSITY OF TEXAS SOUTHWESTERN (UTSW) CENTER FOR ALZHEIMER’S AND NEURODEGENERATIVE DISEASES
In 2018, the Aging Mind Foundation awarded a $700,000 grant to UTSW’s Center for Alzheimer’s and Neurodegenerative Diseases. This grant will fund research to identify molecular mechanisms and therapeutic targets that play a key role in the pathogenesis of disease. The research seeks to develop new therapies and diagnostics for Alzheimer’s that will allow diagnosis and treatment in people before the onset of cognitive problems.